@article{ref1,
title="STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs",
journal="Age and ageing",
year="2020",
author="Seppala, Lotta J. and Petrovic, Mirko and Ryg, Jesper and Bahat, Gulistan and Topinková, Eva and Szczerbinska, Katarzyna and van der Cammen, Tischa J. M. and Hartikainen, Sirpa and Ilhan, Birkan and Landi, Francesco and Morrissey, Yvonne and Mair, Alpana and Gutiérrez-Valencia, Marta and Emmelot-Vonk, Mariëlle H. and Mora, María Ángeles Caballero and Denkinger, Michael and Crome, Peter and Jackson, Stephen H. D. and Correa-Pérez, Andrea and Knol, Wilma and Soulis, George and Gudmundsson, Adalsteinn and Ziere, Gijsbertus and Wehling, Martin and O'Mahony, Denis and Cherubini, Antonio and van der Velde, Nathalie",
volume="ePub",
number="ePub",
pages="ePub-ePub",
abstract="BACKGROUND: Healthcare professionals are often reluctant to deprescribe fall-risk-increasing drugs (FRIDs). Lack of knowledge and skills form a significant barrier and furthermore, there is no consensus on which medications are considered as FRIDs despite several systematic reviews. To support clinicians in the management of FRIDs and to facilitate the deprescribing process, STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk) and a deprescribing tool were developed by a European expert group.   METHODS: STOPPFall was created by two facilitators based on evidence from recent meta-analyses and national fall prevention guidelines in Europe. Twenty-four panellists chose their level of agreement on a Likert scale with the items in the STOPPFall in three Delphi panel rounds. A threshold of 70% was selected for consensus a priori. The panellists were asked whether some agents are more fall-risk-increasing than others within the same pharmacological class. In an additional questionnaire, panellists were asked in which cases deprescribing of FRIDs should be considered and how it should be performed.   RESULTS: The panellists agreed on 14 medication classes to be included in the STOPPFall. They were mostly psychotropic medications. The panellists indicated 18 differences between pharmacological subclasses with regard to fall-risk-increasing properties. Practical deprescribing guidance was developed for STOPPFall medication classes.   CONCLUSION: STOPPFall was created using an expert Delphi consensus process and combined with a practical deprescribing tool designed to optimise medication review. The effectiveness of these tools in falls prevention should be further evaluated in intervention studies.<p /> <p>Language: en</p>",
language="en",
issn="0002-0729",
doi="10.1093/ageing/afaa249",
url="http://dx.doi.org/10.1093/ageing/afaa249"
}